Thus, IL-8 is considered to play a role in the pathogenesis of T-ALL, and quantification of IL-8 levels in leukemia conditions might be more useful and feasible in the clinical setting for the prediction of drug responses, where it may represent a presumptive target for innovative diagnostic and effective therapeutic approaches. Here, CXCL8 is linked to leukemia.